Back

The burden of structural heart valve diseases - Incidence, Prevalence, Treatment Pathways, Quality of Care in the EU.

26 August 2018 (13:04 - 13:12)
Organised by:
Congress Presentation Part of: Current minimally-invasive treatment modalities for heart valve diseases : what is next? Treatment Open Access ESC Congress 2018

About the speaker

Photo
Professor Bernard David Prendergast

St Thomas', London (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Introduction and learning objective - Current minimally-invasive treatment modalities for heart valve diseases: what is next?
Professor M. Gilard (Brest, FR)
Slides Video
Presentation thumbnail
What are current and future treatment modalities? A tailored approach - Aortic stenosis
Professor H. Moellmann (Dortmund, DE)
Slides Video
Presentation thumbnail
What are current and future treatment modalities? A tailored approach - Mitral regurgitation
Doctor A. Latib (New York, US)
Slides Video
Presentation thumbnail
What are current and future treatment modalities? A tailored approach - Tricuspid regurgitation
Doctor M. Enriquez-Sarano (Minneapolis, US)
Slides Video
Presentation thumbnail
Session key takeaways - Current minimally-invasive treatment modalities for heart valve diseases : what is next?
Professor M. Gilard (Brest, FR)
Slides Video

Access the full session

Session thumbnail
Current minimally-invasive treatment modalities for heart valve diseases : what is next?

The Event

Event poster

ESC Congress 2018

26 August 2018 13:04 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources